LeMaitre Vascular, Inc. (LMAT) Q2 2023 Earnings Results

Lemaitre Vascular Beats on EPS, Stock Down 0.65%

Lemaitre Vascular's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 0.65%. This may reflect investor concerns about the lack of revenue data and no updated guidance, which could lead to uncertainty about future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.37	N/A	+14.20%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management conveyed a cautiously optimistic outlook, emphasizing product strength despite supply chain issues. They are focused on innovation and growth.

Management highlighted strong performance in key product lines.

They noted ongoing challenges in the supply chain but expressed confidence in future growth.

Focus remains on innovation and expanding market presence.

Lemaitre Vascular Beats on EPS, Stock Down 0.65%

Key numbers

Management commentary

LeMaitre Vascular, Inc.

More earnings this week

Lemaitre Vascular Beats on EPS, Stock Down 0.65%

Key numbers

Management commentary